By Jeff Montgomery ( March 21, 2022, 4:11 PM EDT) -- Selecta Biosciences Inc. has agreed to limit terms of stock warrants worth millions in cash to directors who participated in a larger, and allegedly unfair, $70 million private placement, as part of a settlement for a Delaware Chancery Court derivative stockholder suit alleging multiple board failures surrounding the deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.